Pharmaceutical Product, Technology Acquisition and Licensing

Consultant #592

Global perspective and experience: Thirty years of licensing dialogues (for GSK, Sanofi-Aventis and Ono) and consulting assignments in Europe, Japan and North America.
Out-licensing partnerships: Establishment of the partnering strategy appropriate to a specific compound and creation of a productive program of contacts and presentation.
In-licensing: Broad, up-to-date familiarity with the executives and activities in biotech firms allowing an efficient program of product identification and the critical dialogue necessary to bring the two parties together.
Transactions: Experienced and successful in negotiating deals with multinational companies and biotech companies for both worldwide and regional licenses.
Japan: Many years of intensive mining of Japanese companies. Working ten years inside a Japanese company resulting in a special perspective and benefit to the challenging task of making deals across cultural boundaries.
Strategic alliances, product licensing, research and development collaborations.
Background in multinational and start-up company environments.
Extensive knowledge of personnel and portfolios in pharmaceutical companies worldwide.
High-level contacts with virtually the entire range of global, mid-sized and biotech companies.
Established a number of broad licensing deals with global players and to explore regional partnerships with hundreds of biotech companies.
Cultivated regional partnerships with hundreds of biotech companies.
Expert witness services.

Undisclosed Company, President, 1994 - Present

Founder and operator of a consultant firm providing corporate business development services to the pharmaceutical and health care sector.
Focus on growth strategies, product and technology licensing on a global or territorial basis and expert witness services.

ONO Pharma, USA, Inc. Vice President of Business Development, 2000 - 2009

Responsible for business development and licensing activities in North America, including identifying promising new business opportunities and negotiating effective partnering agreements.
Out-license partnerships.
In-licensing of development and early-stage products.
Management of alliances.

Sanofi-Aventis, Vice President Licensing, 1986 - 1994

Worldwide responsibility for identification and licensing of product and intellectual property rights for pharmaceuticals and related business transactions.
In-licensing of development-stage oncology agents.
Responsible for establishing strategic alliances in Japan for oncology and diagnostic imaging products.
Licensing of key technologies in support of neurological product development.
Out-licenses in anti-infective, thrombolytic and other areas.
In-licensing of products, patents and technology for diagnostic imaging.
Joint negotiation of a global three-way development/marketing agreement on cardiovascular drugs.
Settlement of patent disputes.
Targeted product acquisition for selected territorial business units.
Academic research collaborations (leading to clinical development projects).

Director of Licensing, 1988 - 1988

Early member of Eastman Kodak Sterling Winthrop Drug (acquired by Sanofi-Aventis) pharmaceutical team, leading to formation of Eastman Pharmaceuticals.
Multi-product oncology in-license.
In-licensed cardiovascular drug; multiple territories.

GlaxoSmithKline, Scientific Director, Licensing, 1973 - 1986

Responsible for scientific and medical evaluation of new product opportunities, implementing licensing strategy in Japan and worldwide licenses for novel drugs.
Developed and maintained business and technical relationships with pharmaceutical companies worldwide.
Worldwide licenses for novel gastrointestinal drugs.
Arranged basic research collaborations with European companies in cardiovascular and gastrointestinal areas.
Developed strategy and initiated establishment of a novel research center in France.
Technology transfer for basic and applied research and development.

University of Minnesota Medical School, Research Associate, 1973 - 1974

Coordinated multi-departmental basic research program and grant on control of growth and function of tumor cells.

Harvard Medical School, Research Fellow and Associate, 1969 - 1972

Academic and Professional Affiliations